Trials / Completed
CompletedNCT01373606
A Study of Terlipressin in Patients With Hepatorenal Syndrome Type 1
An Exploratory Study of FE999908 in Patients With Hepatorenal Syndrome Type 1
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- Ferring Pharmaceuticals · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label, multi-center study, investigating the efficacy and safety of terlipressin in Japanese patients with hepatorenal syndrome type 1.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Terlipressin |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-03-01
- Completion
- 2009-12-01
- First posted
- 2011-06-15
- Last updated
- 2012-02-14
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01373606. Inclusion in this directory is not an endorsement.